AbbVie Inc.

AbbVie is a publicly listed biopharmaceutical firm based in Lake Bluff, Illinois, that was created in 2013 as a spin-off of Abbott Laboratories. This firm creates, manufactures, and distributes biopharmaceuticals and small molecule medications.

AbbVie, another of the world's largest pharmaceutical corporations, was formed after Abbot Laboratories was divided into two businesses. Employees at Abbvie have worked on a variety of pharmaceutical projects, including exploring new ways to cure ailments like Crohn's disease, GARP, and cystic fibrosis. AbbVie Inc. made $33.27 billion in revenue in 2019.

The firm produced $8.619 billion in the first quarter of 2020, up 10.1 percent on a reported basis and 10.7 percent operationally, thanks to a 240 basis point stocking advantage connected to the COVID-19 pandemic. On a reported basis, second-quarter 2020 sales of $10.425 billion and third-quarter 2020 revenue of $12.902 billion represented a 26.3 percent rise and a 52.16 percent increase year-over-year, respectively, including a partial quarter of Allergan and COVID-19 pandemic effects. Abbvie made $31.95 billion in sales in the first three quarters of 2020.

Founded: January 1, 2013
Headquarters: Lake Bluff, Illinois, United States
Market Cap: 206.79B USD
Website: https://www.abbvie.com/